Table 3 Financial gap analysis of malaria (2018–2020)
Product | 2018 (USD) | 2019 (USD) | 2020 (USD) | Total (USD) |
|---|---|---|---|---|
LLINs-MC | 12,837,720 | 14,086,817 | 18,573,253 | 45,497,790 |
LLIN-RD | 5,459,780 | 5,470,368 | 7,330,232 | 18,260,380 |
ACT-public | 8,187,202 | 5,977,085 | 17,953,395 | 32,117,682 |
ACT-community | 2,055,032 | 2,122,437 | 3,925,533 | 8,103,002 |
ACT-private | 74,097,563 | 76,527,963 | 76,432,429 | 227,057,955 |
RDT-public | 1,209,035 | 1,276,307 | 18,487,690 | 20,973,032 |
RDT-community | 199,260 | 205,795 | 283,394 | 688,449 |
RDT-private | 3,320,996 | 3,772,917 | 11,335,763 | 18,429,676 |
Injection artrsunate | 1,257,380 | 1,232,190 | 1,244,312 | 3,733,882 |
Rectal artesunate | 189,420 | 195,633 | 202,049 | 587,102 |
SP-IPTp | 6,708,378 | 7,423,064 | 9,791,623 | 23,923,065 |
SPAQ-SMC | 21,087,775 | 47,077,549 | 47,924,614 | 116,089,938 |
Total | 136,609,541 | 165,368,125 | 213,484,287 | 515,461,953 |